Acomplia Now Also Linked to Anxiety, Depression

One of the newer weight loss drugs has some more bad news unfortunately for those that are overweight and hopeful that this diet product would be the answer to their weight and diet woes.  Before we reported that word on the “street” was that Acomplia was linked to it’s patients having suicidal thoughts, although in a statistically rather small portion of the patients. 

Now, new evidence is showing that patients taking the Acomplia diet drug are showing a doubling in the tendency toward anxiety and depression, which is not good news, especially considering that anxiety and depression are just as bad if not worse than having excess weight, so now patients must decide if the risk is worth the payoff (hopefully substantial weight loss).  Makes natural appetite suppressants pretty appealing, huh?

The study focused on patients taking the drug, and found that patients that were taking 20 milligrams or more of the diet and weightloss product were more than two times likely to stop treatment on the drug due to depression and anxiety cropping up to the point that it seemed unbearable.  This follows an advisory by a panel to not approve the diet drug after findings that it increased suicidal thoughts.